62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

M Gnant; B Mlineritsch; H Stoeger; G Luschin-Ebengreuth; S Poestlberger; G Steger; R Jakesz; C Singer; H Eidtmann; Richard Greil

doi:10.1016/j.bone.2010.10.045

62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

M Gnant
, B Mlineritsch
, H Stoeger
, G Luschin-Ebengreuth
, S Poestlberger
, G Steger
, R Jakesz
, C Singer
, H Eidtmann
, Richard Greil

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	S17-S17
Fachzeitschrift	BONE
Jahrgang	48
Ausgabenummer	1
DOIs	https://doi.org/10.1016/j.bone.2010.10.045
Publikationsstatus	Veröffentlicht - 2011
Veranstaltung	10th International Conference on Cancer - Induced Bone Disease - Sheffield, ENGLAND Dauer: 22 Sept. 2010 → 25 Sept. 2010

Zugriff auf Dokument

10.1016/j.bone.2010.10.045

Dieses zitieren

Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Poestlberger, S., Steger, G., Jakesz, R., Singer, C., Eidtmann, H., & Greil, R. (2011). 62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer. BONE , 48(1), S17-S17. https://doi.org/10.1016/j.bone.2010.10.045

Gnant, M ; Mlineritsch, B ; Stoeger, H et al. / 62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer. in: BONE 2011 ; Jahrgang 48, Nr. 1. S. S17-S17.

@article{82ec0fd066a84072a9ca056fb12f92da,

title = "62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer",

author = "M Gnant and B Mlineritsch and H Stoeger and G Luschin-Ebengreuth and S Poestlberger and G Steger and R Jakesz and C Singer and H Eidtmann and Richard Greil",

year = "2011",

doi = "10.1016/j.bone.2010.10.045",

language = "English",

volume = "48",

pages = "S17--S17",

journal = "BONE ",

issn = "8756-3282",

publisher = "Elsevier ",

number = "1",

note = "10th International Conference on Cancer - Induced Bone Disease ; Conference date: 22-09-2010 Through 25-09-2010",

}

Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Poestlberger, S, Steger, G, Jakesz, R, Singer, C, Eidtmann, H & Greil, R 2011, '62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer', BONE , Jg. 48, Nr. 1, S. S17-S17. https://doi.org/10.1016/j.bone.2010.10.045

62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer. / Gnant, M; Mlineritsch, B; Stoeger, H et al.
in: BONE , Jahrgang 48, Nr. 1, 2011, S. S17-S17.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - 62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

AU - Gnant, M

AU - Mlineritsch, B

AU - Stoeger, H

AU - Luschin-Ebengreuth, G

AU - Poestlberger, S

AU - Steger, G

AU - Jakesz, R

AU - Singer, C

AU - Eidtmann, H

AU - Greil, Richard

PY - 2011

Y1 - 2011

U2 - 10.1016/j.bone.2010.10.045

DO - 10.1016/j.bone.2010.10.045

M3 - Abstract (Journal)

SN - 8756-3282

VL - 48

SP - S17-S17

JO - BONE

JF - BONE

IS - 1

T2 - 10th International Conference on Cancer - Induced Bone Disease

Y2 - 22 September 2010 through 25 September 2010

ER -

Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Poestlberger S, Steger G et al. 62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer. BONE . 2011;48(1):S17-S17. doi: 10.1016/j.bone.2010.10.045